Hepatic toxicity secondary to hypervitaminosis A is extremely rare. We report the case of a 27-year-old Caucasian female who presented for an investigation of abdominal pain, cholestatic liver function tests, and abnormal computerized tomography findings. She had been prescribed isotretinoin for her acne and had subsequently purchased vitamin A online, which she consumed daily for over 18 months.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144761PMC
http://dx.doi.org/10.1002/jgh3.12201DOI Listing

Publication Analysis

Top Keywords

liver toxicity
4
toxicity vitamin
4
vitamin hepatic
4
hepatic toxicity
4
toxicity secondary
4
secondary hypervitaminosis
4
hypervitaminosis extremely
4
extremely rare
4
rare report
4
report case
4

Similar Publications

The current study aimed to assess the preventive effects of aqueous leaf extract of Pistacia lentiscus (ALEPL) against Oxaliplatin (OXA)-induced DNA damage, hepatic injury, and oxidative stress. The in vitro cytotoxic and genotoxic effects of OXA and ALEPL on HCT116 colon cancer cells were evaluated using the MTT (Tetrazolium salt reduction) assay and comet assay. The in vivo study involved 24 female NMRI (Naval Medical Research Institute) mice that were equally divided into four groups as follows: Control group, ALEPL-treated group (100 mg/kg), OXA-treated group (7 mg/kg), and ALEPL-treated group (100mg/kg) + OXA (7mg/kg).

View Article and Find Full Text PDF

This study aimed to provide insights into the hepatorenal toxicity induced by erythrosine, a synthetic red dye commonly used in food and pharmaceuticals, which has raised concerns over its potential health risks. Twenty-four rats were randomly divided into four groups (n = 6). The first group was the control group and the other group received one of three doses of erythrosine based on acceptable daily intake (¼ ADI, ½ ADI, and ADI, 0.

View Article and Find Full Text PDF

Hepatobiliary Adverse Events Associated With the KRAS p.G12C Inhibitor Sotorasib.

Pharmacoepidemiol Drug Saf

February 2025

Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Purpose: The p.G12C mutation in KRAS is commonly found in many cancers and was previously untreatable until drugs like sotorasib were developed. However, up to 15% of patients treated with sotorasib have experienced hepatobiliary adverse events.

View Article and Find Full Text PDF

The Safety Profile of Amiodarone Among Older Adults (age ≥ 75 years): A Pharmacovigilance Study from the FDA Data.

Am J Med

January 2025

The Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Sheba Medical Center, Ramat-Gan, Israel; Division of Geriatric Medicine, University of Pittsburgh Medical Center, Pittsburgh, PA, USA. Electronic address:

Background: Amiodarone is a widely used antiarrhythmic agent with significant toxicities and drug interactions more likely to affect older adults. Nevertheless, data regarding amiodarone safety in this population are limited.

Methods: We conducted a retrospective analysis of FDA Adverse Event Reporting System (FAERS) data from 2003 to 2024 .

View Article and Find Full Text PDF

Is ChatGPT ready for public use in organ-specific drug toxicity research?

Drug Discov Today

January 2025

National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR 72079, USA. Electronic address:

The growing impact of large language models (LLMs), such as ChatGPT, prompts questions about the reliability of their application in public health. We compared drug toxicity assessments by GPT-4 for liver, heart, and kidney against expert assessments using US Food and Drug Administration (FDA) drug-labeling documents. Two approaches were assessed: a 'General prompt', mimicking the conversational style used by the general public, and an 'Expert prompt' engineered to represent an approach of an expert.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!